glp-1 insurance coverage change impacts millions of Americans: What to know, how to tell if you're covered GLP-1 Insurance Coverage for Weight

Ipamorelin belongs to the most recent generation of GHRPs from the mid 1990s and causes significant release of growth hormone by itself, due both to its suppression of somatostatin (an antagonist to GHRH) and stimulation of release of GH from the anterior pituitary, similar to GHRP-2 and GHRP-6 which are compounds from the same class (growth hormone releasing peptides).[1] The cells that produce and release GH are known as somatotropes.[2] Like GHRP-2, ipamorelin does not have ghrelins lipogenic properties

Lets see what existing studiesalbeit mostly in animalstell us

Instead, it supports the body's natural energy production processes over time

Li M, Li CM, Ye ZC, Huang J, Li Y, Lai W, et al

In the international survey, 75.2% of participants used semaglutide and 19.9% used tirzepatide